Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Affymetrix, Inc.    AFFX

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops, manufactures and sells products and services for genetic analysis

Affymetrix, Inc. provides life science and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein and cell level.

It develops, manufactures and sells products and services for genetic analysis to the genomic research centers, academic institutions, government and private laboratories, as well as pharmaceutical, diagnostic and biotechnology companies.

The company operates through two segments: Affymetrix Core and eBioscience.

The Affymetrix Core segment is divided into four business units, namely The Expression, The Genetic Analysis and The Clinical Applications, The Life Science Reagents and Corporate.

The Expression business unit develops and markets the company's GeneChip gene expression products and services; Genetic Analysis and Clinical Applications business unit develops and markets the company's genotyping, such as the Axiom product line and arrays with clinical research applications, such as the CytoScan cytogenetics arrays; Life Science Reagents business unit develops and sells reagents, enzymes, purification kits and biochemical's used by life science researchers and Corporate business unit is comprised of revenue from royalty arrangements, and field revenue from services provided to customers by the company . The eBioscience segment specializes in the development, manufacturing, marketing and distribution of research tools in the areas of flow cytometry, immunoassays, microscopic imaging and other protein-based analyses.

The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA.
Managers
NameAgeSinceTitle
Franklin R. Witney, PhD622011President, Chief Executive Officer & Director
Jami K. Dover Nachtsheim572010Chairman
Andrew J. Last, PhD562009Chief Operating Officer & Executive Vice President
Gavin Wood462006Chief Financial Officer & Executive Vice President
Robert H. Trice Jr., PhD692006Independent Director
Gary Guthart502009Independent Director
Nelson C. Chan, MBA542010Independent Director
Merilee Raines, MBA602015Independent Director
Riccardo Pigliucci692015Director
Mindy Lee-Olsen--VP-Marketing Services & Media Relations Contact
Shareholders
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Diagnostics & Testing
Advertisement
Sector Biotechnology & Medical Research
Growth (Revenue) Profitability
DA AN GENE CO., L..
-
MIRACA HOLDINGS I..
AFFYMETRIX, INC.
SEEGENE INC
INNATE PHARMA
VERACYTE INC
PANAGENE INC
-
MEDICAL&BIOLOGICA..
-
EPIGENOMICS AG
-
VERMILLION, INC.
-
EXIQON A/S
TRANS GENIC INC.
-
CAREDX INC
MEDIBIC GROUP
-
ALLENEX AB
-
SOIKEN HOLDINGS I..
-
VIMTA LABS LTD
-
THERADIAG
AB-BIOTICS SA
-
DNA CHIP RESEARCH..
-
Sector Biotechnology & Medical Research
Affymetrix, Inc. : Connections
Akros Silicon, Inc.
Lockheed Martin UK Ltd.
DVS Sciences, Inc.
Exagen Diagnostics, Inc.
The Tech Museum of Innovation
Nanosys, Inc.
RareCyte, Inc.
Lockheed Martin Overseas Services Corp.
Bridgelux, Inc.
MedaPhor Ltd.
One Lambda, Inc.
Aldwych Associates LLP
Company contact information
Affymetrix, Inc.
3420 Central Expressway
Santa Clara, CA 95051

Phone : +1.408.731.5000
Fax : +1.408.731.5380
Web : www.affymetrix.com
© 2016 People , Fundamentals and Ownership